Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Shayahati Bieerkehazhi(Population Health Research Institute), Jianhua Yang(Children's National)
Oncotarget
November 26, 2016
Cited by 39


Related Papers